Trial Details

WITHDRAWN
Basic Information
Clinical ID c2157
Identifier NCT03905109
Trial Title Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: ABX464|DRUG: Placebo
Participant Information
Sponsor Abivax S.A.
City Leuven
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2022-09-19
Primary Completion Date 2022-09-19
Completion Date 2022-09-19